These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 19017430)

  • 21. Psychosis reactivity to cannabis use in daily life: an experience sampling study.
    Henquet C; van Os J; Kuepper R; Delespaul P; Smits M; Campo JA; Myin-Germeys I
    Br J Psychiatry; 2010 Jun; 196(6):447-53. PubMed ID: 20513854
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cannabis and psychosis: Does cannabis really cause psychosis?
    Macdonald AJ
    BMJ; 2006 Feb; 332(7536):303. PubMed ID: 16455739
    [No Abstract]   [Full Text] [Related]  

  • 23. Blunted psychotomimetic and amnestic effects of delta-9-tetrahydrocannabinol in frequent users of cannabis.
    D'Souza DC; Ranganathan M; Braley G; Gueorguieva R; Zimolo Z; Cooper T; Perry E; Krystal J
    Neuropsychopharmacology; 2008 Sep; 33(10):2505-16. PubMed ID: 18185500
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Symptomatology and neuropsychological functioning in cannabis using subjects at ultra-high risk for developing psychosis and healthy controls.
    Korver N; Nieman DH; Becker HE; van de Fliert JR; Dingemans PH; de Haan L; Spiering M; Schmitz N; Linszen DH
    Aust N Z J Psychiatry; 2010 Mar; 44(3):230-6. PubMed ID: 20180725
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cannabis use and age at onset of symptoms in subjects at clinical high risk for psychosis.
    Dragt S; Nieman DH; Schultze-Lutter F; van der Meer F; Becker H; de Haan L; Dingemans PM; Birchwood M; Patterson P; Salokangas RK; Heinimaa M; Heinz A; Juckel G; Graf von Reventlow H; French P; Stevens H; Ruhrmann S; Klosterkötter J; Linszen DH;
    Acta Psychiatr Scand; 2012 Jan; 125(1):45-53. PubMed ID: 21883099
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Subclinical depressive symptoms and continued cannabis use: predictors of negative outcomes in first episode psychosis.
    González-Ortega I; Alberich S; Echeburúa E; Aizpuru F; Millán E; Vieta E; Matute C; González-Pinto A
    PLoS One; 2015; 10(4):e0123707. PubMed ID: 25875862
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pre-illness cannabis use and the early course of nonaffective psychotic disorders: associations with premorbid functioning, the prodrome, and mode of onset of psychosis.
    Compton MT; Broussard B; Ramsay CE; Stewart T
    Schizophr Res; 2011 Mar; 126(1-3):71-6. PubMed ID: 21036542
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The psychosis-like effects of Δ(9)-tetrahydrocannabinol are associated with increased cortical noise in healthy humans.
    Cortes-Briones JA; Cahill JD; Skosnik PD; Mathalon DH; Williams A; Sewell RA; Roach BJ; Ford JM; Ranganathan M; D'Souza DC
    Biol Psychiatry; 2015 Dec; 78(11):805-13. PubMed ID: 25913109
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anxiety mediates the association between cannabis use and attenuated positive psychotic symptoms.
    Reeves LE; Anglin DM; Heimberg RG; Gibson LE; Fineberg AM; Maxwell SD; Kerns CM; Ellman LM
    Psychiatry Res; 2014 Aug; 218(1-2):180-6. PubMed ID: 24745470
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Temporal relationship of first-episode non-affective psychosis with cannabis use: a clinical verification of an epidemiological hypothesis.
    Barrigón ML; Gurpegui M; Ruiz-Veguilla M; Diaz FJ; Anguita M; Sarramea F; Cervilla J
    J Psychiatr Res; 2010 May; 44(7):413-20. PubMed ID: 19900684
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cannabis use and childhood trauma interact additively to increase the risk of psychotic symptoms in adolescence.
    Harley M; Kelleher I; Clarke M; Lynch F; Arseneault L; Connor D; Fitzpatrick C; Cannon M
    Psychol Med; 2010 Oct; 40(10):1627-34. PubMed ID: 19995476
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Schizotypy and psychosis-like experiences from recreational cannabis in a non-clinical sample.
    Barkus E; Lewis S
    Psychol Med; 2008 Sep; 38(9):1267-76. PubMed ID: 18205966
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hyper-priming in cannabis users: a naturalistic study of the effects of cannabis on semantic memory function.
    Morgan CJ; Rothwell E; Atkinson H; Mason O; Curran HV
    Psychiatry Res; 2010 Apr; 176(2-3):213-8. PubMed ID: 20122742
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cannabis-induced psychosis and subsequent schizophrenia-spectrum disorders: follow-up study of 535 incident cases.
    Arendt M; Rosenberg R; Foldager L; Perto G; Munk-Jørgensen P
    Br J Psychiatry; 2005 Dec; 187():510-5. PubMed ID: 16319402
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of cannabis and psychosis vulnerability in daily life: an experience sampling test study.
    Verdoux H; Gindre C; Sorbara F; Tournier M; Swendsen JD
    Psychol Med; 2003 Jan; 33(1):23-32. PubMed ID: 12537033
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cannabis--psychosis pathway independent of other types of psychopathology.
    Ferdinand RF; van der Ende J; Bongers I; Selten JP; Huizink A; Verhulst FC
    Schizophr Res; 2005 Nov; 79(2-3):289-95. PubMed ID: 16125368
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cannabis, COMT and psychotic experiences.
    Zammit S; Owen MJ; Evans J; Heron J; Lewis G
    Br J Psychiatry; 2011 Nov; 199(5):380-5. PubMed ID: 21947654
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cannabis use and dimensions of psychosis in a nonclinical population of female subjects.
    Verdoux H; Sorbara F; Gindre C; Swendsen JD; van Os J
    Schizophr Res; 2003 Jan; 59(1):77-84. PubMed ID: 12413646
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Childhood trauma mediates the association between ethnic minority status and more severe hallucinations in psychotic disorder.
    Berg AO; Aas M; Larsson S; Nerhus M; Hauff E; Andreassen OA; Melle I
    Psychol Med; 2015 Jan; 45(1):133-42. PubMed ID: 25065296
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Different psychological effects of cannabis use in adolescents at genetic high risk for schizophrenia and with attention deficit/hyperactivity disorder (ADHD).
    Hollis C; Groom MJ; Das D; Calton T; Bates AT; Andrews HK; Jackson GM; Liddle PF
    Schizophr Res; 2008 Oct; 105(1-3):216-23. PubMed ID: 18768298
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.